You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH)控股子公司轉讓“健胃愈瘍顆粒”生產技術
格隆匯 06-15 16:34

格隆匯6月15日丨方盛製藥(603998.SH)公佈,公司控股子公司湖南湘雅製藥有限責任公司(以下簡稱“湘雅製藥”)委託湖南省聯合產權交易所(以下簡稱“湖南聯交所”)組織轉讓“健胃愈瘍顆粒”的藥品生產技術,通過自由競價,由湖南奧維康醫藥有限公司(以下簡稱“奧維康”)以381萬元成功競買;湘雅製藥將“健胃愈瘍顆粒”的藥品生產技術轉讓給奧維康。

健胃愈瘍顆粒是以柴胡、黨蔘、白芍、延胡索、白及、珍珠層粉、青黛、甘草等中藥組成,具有補氣活血、益氣養陰、寧心安神的功效,疏肝健脾,生肌止痛。用於肝鬱脾虛,肝胃不和所致的胃痛,症見脘腹脹痛、噯氣吞酸、煩躁不適、腹脹便溏;消化性潰瘍見上述證候者。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account